Abstract: Low-density lipoproteins (LDLs) are ac lass of nanocarriers for the targeted delivery of therapeutics into aberrant cells that overexpress the LDL receptor.Afacile procedure is used for reconstituting the hydrophobic core of LDLs with abinary fatty acid mixture.Facilitated by the tumor targeting capability of the apolipoprotein, the reconstituted, drug-loaded LDLs can effectively target cancer cells that overexpress the LDL receptor while showing minor adverse impact on normal fibroblasts.A ccording to ah ypothesized mechanism, the reconstituted LDLs can also enable metabolism-triggered drug release while preventing the payloads from lysosomal degradation. This study demonstrates that LDLs reconstructed with fatty acids hold great promise to serve as effective and versatile nanocarriers for targeted cancer therapy.
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Low-density lipoproteins (LDLs) have been explored as anovel class of nanocarriers for targeted delivery of imaging contrast agents and therapeutics into aberrant cells owing to their small sizes (< 50 nm), biodegradability,a nd long blood circulation time (2-4 days).
[1] Structurally,e ach LDL has au nique,w ell-defined architecture constructed from an amphiphilic phospholipid monolayer and ah ydrophobic core comprised of more than 45 wt %c holesteryl ester. [1a,c, 2] Its surface is decorated by an apolipoprotein B-100 macromolecule that can be specifically recognized by the LDL receptor.
[3] Upon binding between apolipoprotein B-100 and the receptor,e ndocytosis will be triggered to attain cholesterol intake.Incontrast with normal tissues,the LDL receptor is up-regulated in many types of malignant cells or tissues. [4] This unique feature allows LDLs to serve as aclass of natural nanocarriers for tumor-targeted drug delivery.
Currently,t hree strategies have been developed to introduce payloads into LDLs,i ncluding non-covalent intercalation into the phospholipid monolayer,e ncapsulation in the hydrophobic core,a nd covalent conjugation with the apolipoprotein. [1a,b] Encapsulation in the core is particularly well-suited for drug delivery because of the simple procedure and relatively large loading capacity.T he encapsulation process typically involves core reconstitution that uses anonpolar organic solvent to extract the hydrophobic lipids and subsequently refills the resultant void spaces with amixture of cholesterol esters and drugs or cholesterol-drug conjugates. However,t he presence of excess cholesterol in the bloodstream greatly increases the risk of forming atherosclerotic plaques in the aortic vasculature,w hich may cause fatal diseases such as myocardial infarction and stroke. [5] Therefore,t he cholesterol/cholesteryl ester formulation should be avoided and preferably replaced with other naturally occurring compounds.
Fatty acids,animportant source of stored energy in living organisms,h ave been exploited as ac lass of promising biomaterials owing to their biocompatibility and biodegradability. [6] In the present study,weused amixture of fatty acids as the hydrophobic matrix to reconstitute the native LDLs through ac ore-loading approach ( Figure 1a ). Differential scanning calorimetry (DSC) was used to measure the melting points of mixtures derived from lauric acid (m.p. = 45 8 8C) and stearic acid (m.p. = 69 8 8C). At aw eight ratio of 4:1, we Figure 1 . a) Illustration showing alow-density lipoprotein (LDL) nanoparticle in which the core has been reconstitutedw ith adrug-loaded mixture of fatty acids. Abbreviations:PLphospholipid,C Lcholesterol, FAs fatty acids, CE cholesteryl ester,PApayload.b )DSC curves of lauric acid, stearic acid, and ab inary mixture of lauric acid and stearic acid at aw eight ratio of 4:1. c)-e) TEM images of c) native LDLs, d) C6-LDLs, and e) DOX-LDLs. These nanoparticles were negatively stained with 2wt% aqueousp hosphotungstic acid prior to characterization. Scale bars:1 00 nm.
obtained ae utectic mixture with as harp melting point at 39 8 8C ( Figure 1b) , which is slightly higher than the normal human body temperature (37 8 8C). As such, the payloads can be effectively encapsulated without prominent leakage until being triggered for release at the target site.Itis worthnoting that lauric acid has af avorable effect on the increase of "good" blood cholesterol (high-density lipoprotein), whereas stearic acid enables the decrease of "bad" blood cholesterol (LDL). [7] As such, these naturally occurring compounds can be considered as safe materials for the substitution of cholesterol ester in LDL reconstitution. We then adopted the Kriegersmethod with minor modifications to reconstruct the core of native LDLs. [8] Specifically,t he endogenous core lipids were extracted and then replaced with the eutectic mixture of lauric acid and stearic acid. Our quantitative analysis indicates that about 50 wt %ofthe total cholesterols (including free cholesterol and cholesteryl ester) could be removed using this method, providing adequate spaces for subsequent core loading (Supporting Information, Table S1 ). Thes tructural stability of LDLs before and after reconstitution was also confirmed by UV/Vis and circular dichroism (CD) spectra (Supporting Information, Figure S1 ). The characteristic absorption peak of apolipoprotein B-100 at 280 nm and the unique spectrum of ap rimarily a-helical protein with an egative peak at ca. 210 nm were both preserved, [9] indicating that the reconstitution process did not alter the structure of apolipoprotein B-100. Thepayloads, together with the binary fatty acids,w ere then core-loaded into the LDLs.U nder ambient conditions,t he fatty acids became solidified, facilitating the entrapment of the payloads in the matrix. Since the hydrophobic cavity of native LDLs prefers to accommodate hydrophobic substances,the loading mechanism is supposed to be the hydrophobic interactions between fatty acids and the payloads.
Them orphology and integrity of the resultant rLDLs were examined using transmission electron microscopy (TEM). Both C6-reconstituted LDLs (C6-LDLs) and DOXreconstituted LDLs (DOX-LDLs) exhibited good dispersity and as pherical shape essentially identical to those of native LDLs,s uggesting that the reconstitution process only had anegligible impact on the morphology of the initial template (Figure 1c-e) . We further quantified the size distribution of the resultant particles.R elative to native LDLs,t he rLDLs were slightly enlarged in size ( Supporting Information, Figure S2) . Meanwhile,asomewhat broader distribution in size was found for DOX-LDLs.The slight increase in particle size can be attributed to the overloading of fatty acids,a sw ell as the difference in molecular stacking between fatty acids and cholesteryl esters.T he UV/Vis spectra shown in the Supporting Information, Figure S3 confirm the presence of C6 and DOX, demonstrating that the payloads had been successfully loaded into the rLDLs.F urther quantification indicates that the average numbers of C6, DOX, lauric acid, and stearic acid contained in each LDL particle were 10 AE 1, 25 AE 3, 1367 AE 73, and 241 AE 13, respectively (Supporting Information, Table S2 ). Compared to C6, the loading capacity of DOXi n the rLDLs was higher, which can be attributed to as tronger interaction between DOXand the fatty acids according to the principle of "like dissolves like".
We next studied the difference in receptor-mediated uptake of C6-LDLs between cancerous and normal cells. An in vitro assay was performed using A549 lung cancer cells and NIH-3T3 fibroblast cells that overexpress and moderately express the LDL receptor,r espectively. [10] After incubation for 3h,weobserved asubstantial accumulation of C6-LDLs inside the A549 cells (Figure 2a) . Theo verlay image demonstrates that most C6-LDLs were co-localized with Lysotracker (late endosome/lysosome marker), suggesting that the particles entered cells via an endocytic pathway.T he punctate green fluorescence in the periphery of the cells can be ascribed to the newly bounded C6-LDLs or early internalization events.Incomparison, the fluorescence intensity of C6 in NIH-3T3 cells was much weaker than that in A549 cells (Figure 2b) . Moreover,the fluorescence signals could only be detected around the edge of the cell rather than the cytoplasm because of the relatively slow internalization and/or nonspecific binding.
To verify that the internalization process was primarily mediated by the LDL receptor,weinvestigated the uptake of C6-LDLs in the presence of 20-fold excess of native LDLs (Figure 2c and d) . Receptor blocking greatly decreased the uptake of C6-LDLs in both A549 and NIH-3T3 cells,w ith barely noticeable fluorescence in the cytoplasm. To quantify the differential receptor-mediated uptake in both cell lines, flow cytometric analysis was performed. As shown in Figure 2e and f, there was am ore pronounced peak shift for A549 cells than NIH-3T3 cells after incubation with C6-LDLs,i ndicating the targeting selectivity of rLDLs toward cancer cells over normal cells.I nt he presence of 20-fold excess of native LDLs,the population of both A549 and NIH-3T3 cells substantially shifted toward the direction with low fluorescence intensities.F urther quantification indicates that after receptor blocking,there was 60-fold and 3-fold decrease in mean fluorescence intensity for A549 and NIH-3T3 cells, respectively (Supporting Information, Figure S4 ). Thed ata confirm that the rLDLs maintain the biological functions of native LDLs and still have ap referential affinity toward cancer cells that overexpress the LDL receptor.
We then investigated the intracellular drug delivery using DOX-LDLs.A ss hown in Figure 3a and b, the A549 cells exhibited punctate red fluorescence,w hereas the fluorescence signal was barely detected from the NIH-3T3 cells.This finding further confirms the higher affinity of DOX-LDLs toward cancer cells.I ti sw orth noting that the fluorescence signals of DOX in some A549 cells were overlaid with the nuclei rather than being clustered in the cytoplasm, indicating the translocation of DOXi nto the nuclei. After internalization, the DOX-LDLs would be transported to the endo/ lysosomes.S ince fatty acids cannot be hydrolyzed, the therapeutic drugs are supposed to be protected from lysosomal degradation. However,c ancer cells have an elevated energy demand to maintain rapid proliferation. [11] This,i n turn, triggers the release of the fatty acids and payloads.Over time,t he released DOX intercalates into the deoxyribonucleic acids (rich in the nuclei)t oi nhibit the proliferation of cancer cells.
We then measured the release profile of DOX from the DOX-LDLs in phosphate buffered saline.A ss hown in the Supporting Information, Figure S5 , the DOX exhibited al imited and sustained release behavior over 24 h. We hypothesized that both the phospholipid shell and the fatty acid core could act as aphysical barrier to slow down the drug release.T oq uantitatively evaluate the targeted toxicity of DOX-LDLs,w ep erformed cell viability analyses.F igure 3c shows the dose-dependent growth inhibition of the DOXLDLs on A549 cells.A st he concentration of DOX-LDLs increased, the cell viability decreased significantly.When the concentration of DOX in DOX-LDLs reached 3.6 mm,t he inhibitory rate was as high as 98 %. TheI C50 value was determined to be 2.3 mm,w hich was much lower than that of free DOX (14.6 mm), indicating the efficacyo ft he proposed metabolism-triggered drug release (Supporting Information, Figure S6 ). In contrast, NIH-3T3 cells exhibited ar esistance to DOX-LDLs under all tested concentrations as ar esult of the limited uptake of the rLDLs.Even for the group with the highest amount of DOX, NIH-3T3 cells still showed asurvival rate of over 70 %.
We have also sought to simplify the delivery system by using just one of the fatty acids.H owever,t he LDLs reconstituted from either lauric acid or stearic acid could not efficiently trap the DOX molecules owing to the high crystallinity associated with single-component fatty acid, which results in drug efflux during solvent evaporation (Supporting Information, Table S3 ). Theb inary fatty acid mixture could reduce the crystallinity of the system and thus keep drugs in the solid matrix. Furthermore,e ven under the same DOXc oncentrations,b oth lauric acid and stearic acid exhibited less prominent cytotoxicity against A549 cells, which is probably due to the ineffective drug release from as olid matrix with an elevated melting point (Supporting Information, Figure S7 ). Taken together,i ti sn ecessary to manipulate the thermal properties of fatty acids to facilitate rapid and efficient drug release.
To verify the LDL receptor-mediated cytotoxicity,w e conducted ar eceptor blocking assay with 20-fold excess of native LDLs.Asshown in Figure 3d ,the competitive binding remarkably suppressed the cytotoxicity of DOX-LDLs toward A549 cells,a nd the cell viability was recovered to the same level as that of excess LDLs alone.However,wedid not observe any increased survival rate for the blocking group of NIH-3T3 cells.Conversely,the excess LDLs and cytotoxic DOX-LDLs imposed ac oncerted inhibitory effect on the viability of NIH-3T3 cells.The cell survival condition was also examined using inverted optical microscopy (Supporting Information, Figure S8 ). Fort he group incubated with DOX-LDLs,A 549 cells exhibited an apoptotic phenotype with ah ighly shrunk and rounded shape.R eceptor blocking with excess LDLs greatly rescued the cells to ahealthy living status.A sf or NIH-3T3 cells,n oo bvious cell apoptosis was found for all groups,s uggesting that the internalized DOX molecules were not enough to initiate noticeable cytotoxicity.
We also evaluated in vivo accumulation of the fatty acidreconstituted LDLs in B16-F10 melanoma-bearing mice as the LDL receptor is known to be upregulated in melanoma cells. [12] We first confirmed the receptor-mediated uptake of the rLDLs using B16-F10 murine melanoma cells in vitro (Supporting Information, Figure S9 ). To facilitate in vivo fluorescent detection, an ear-infrared dye,I R780 iodide (IR780), was incorporated into LDLs to obtain IR780-LDLs,w hich were then used for the study of in vivo biodistribution and competitive binding in subcutaneous B16-F10 melanoma-bearing C57BL/6 mice.A ss hown in Figure 4a ,t he IR780-LDLs were able to accumulate in the solid tumors,a nd co-injection of IR780-LDLs and 20-fold excess of native LDLs significantly reduced their enrichment at these sites.W ef urther quantified the average radiant efficiency (ARI) in these tumors.A ss hown in Figure 4b , receptor blocking by excess LDLs resulted in a2 .2-fold decrease in ARI, indicating that the receptor-mediated endocytosis probably plays ap rimary role in the uptake of these nanoparticles.The distribution of IR780-LDLs in major organs was also examined (Supporting Information , Figure S10) . Since the B16-F10 melanoma has ablack color,both the excitation light and fluorescence signals of IR780 were greatly attenuated owing to its self-absorption. As such, it is difficult to make parallel comparison between the major organs and the tumor based on the ARI. Nevertheless,t he data shown in Figure 4suggest that the biological functions of rLDL were maintained and the rLDLs can be used to target tumors that overexpress the LDL receptor.
In summary,LDLs reconstituted from ab inary fatty acid mixture have been developed as ab iocompatible,t umortargeting nanocarrier for the delivery of both imaging contrast agents and anticancer drugs.T he reconstitution process has essentially no impact on the morphology and biological functions of LDLs.I nt erms of using fatty acid as amatrix for drug loading,t here are an umber of advantages. First, fatty acids are naturally occurring biomolecules,i ndicating good biocompatibility and biodegradability.S econd, fatty acids are an important class of fuel source.S ince the rapidly proliferating cancer cells have ah igher demand on energy,w eh ypothesize that the metabolism-triggered drug release will be augmented. Third, all molecules transported to lysosomes are inevitably hydrolyzed into reusable small units. Fatty acids,t he smallest units in lysosomes,a re supposed to protect the payloads from hydrolysis and thus facilitate endolysosomal escape.A ll these features contribute to the rapid and effective cytotoxicity toward cancer cells,m aking the fatty acid-reconstituted LDLs apromising nanocarrier for targeted cancer therapy. ). Significant differenceb etween the tumors with or without receptor blocking is indicated (**, p < 0.005).
